default author photo

Olivia A.C. Lamers

Leiden University - Department of Infectious Diseases

SCHOLARLY PAPERS

1

DOWNLOADS

90

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Chemoprophylactic Activity of M5717 Against Plasmodium Falciparum in a Controlled Human Malaria Infection

Number of pages: 36 Posted: 22 Nov 2022
Centre for Human Drug Research, Leiden University - Department of Infectious Diseases, Merck Serono S.A. (an affiliate of Merck KGaA, Darmstadt, Germany) - Merck Institute for Pharmacometrics, Merck Healthcare KGaA, Merck Healthcare KGaA, Merck Healthcare KGaA, Merck Healthcare KGaA, Ares Trading S.A. (a subsidiary of Merck KGaA, Darmstadt, Germany) - Global Health Institute of Merck, Merck (Pty) Ltd (an affiliate of Merck KGaA, Darmstadt, Germany), Occams, Ares Trading S.A. (a subsidiary of Merck KGaA, Darmstadt, Germany) - Global Health Institute of Merck, Hemogenyx Pharmaceuticals, Columbia University - Department of Microbiology and Immunology, Columbia University - Department of Microbiology and Immunology, Centre for Human Drug Research, Leiden University - Department of Parasitology, Leiden University - Department of Infectious Diseases, Leiden University - Department of Infectious Diseases, Leiden University - Department of Infectious Diseases, Leiden University - Department of Infectious Diseases, Leiden University - Department of Medical Microbiology, Leiden University - Center for Cell and Gene Therapy, Centre for Human Drug Research, Leiden University - Department of Infectious Diseases and Ares Trading S.A. (a subsidiary of Merck KGaA, Darmstadt, Germany) - Global Health Institute of Merck
Downloads 90 (747,755)

Abstract:

Loading...

Adaptive intervention, Chemoprevention, Healthy participants, M5717, Malaria